|
1
|
Kim J, Kim N, Park JH, Chang H, Kim JY,
Lee DH, Kim JM, Kim JS and Jung HC: The effect of Helicobacter
pylori on epidermal growth factor receptor-induced signal
transduction and the preventive effect of celecoxib in gastric
cancer cells. Gut Liver. 7:552–529. 2013.
|
|
2
|
Jian P, Yanfang T, Zhuan Z, Jian W,
Xueming Z and Jian N: MMP28 (epilysin) as a novel promoter of
invasion and metastasis in gastric cancer. BMC Cancer. 11:2002011.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Atmaca A, Pauligk C, Steinmetz K,
Altmannsberger HM, Jäger E and Al-Batran SE: Prognostic impact of
phosphorylated mitogen-activated protein kinase expression in
patients with metastatic gastric cancer. Oncology. 80:130–134.
2011. View Article : Google Scholar
|
|
4
|
Oh SC: Update of adjuvant chemotherapy for
resected gastric cancer. J Gastric Cancer. 12:3–6. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kingma PS and Osheroff N: Topoisomerase
II-mediated DNA cleavage and religation in the absence of base
pairing. Abasic lesions as a tool to dissect enzyme mechanism. J
Biol Chem. 273:17999–18002. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Huang J, Ni J, Liu K, Yu Y, Xie M, Kang R,
Vernon P, Cao L and Tang D: HMGB1 promotes drug resistance in
osteosarcoma. Cancer Res. 72:230–238. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wu K, Xie D, Zou Y, Zhang T, Pong RC, Xiao
G, Fazli L, Gleave M, He D, Boothman DA and Hsieh JT: The mechanism
of DAB2IP in chemoresistance of prostate cancer cells. Clin Cancer
Res. 19:4740–4749. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang YI, Lee KT, Park HJ, Kim TJ, Choi YS,
Shih IeM and Choi JH: Tectorigenin sensitizes paclitaxel-resistant
human ovarian cancer cells through downregulation of the Akt and
NFκB pathway. Carcinogenesis. 33:2488–2498. 2012.PubMed/NCBI
|
|
9
|
Marengo B, De Ciucis CG, Ricciarelli R,
Furfaro AL, Colla R, Canepa E, Traverso N, Marinari UM, Pronzato MA
and Domenicotti C: p38MAPK inhibition: a new combined approach to
reduce neuroblastoma resistance under etoposide treatment. Cell
Death Dis. 4:e5892013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cuenda A and Rousseau S: p38 MAP-kinases
pathway regulation, function and role in human diseases. Biochim
Biophys Acta. 1773:1358–1375. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Keuling AM, Andrew SE and Tron VA:
Inhibition of p38 MAPK enhances ABT-737-induced cell death in
melanoma cell lines: novel regulation of PUMA. Pigment Cell
Melanoma Res. 23:430–440. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Feng R, Zhai WL, Yang HY, Jin H and Zhang
QX: Induction of ER stress protects gastric cells against apoptosis
induced by cisplatin and doxorubicin through activation of p38
MAPK. Biochem Biophys Res Commun. 406:299–304. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Harrington KJ, Rowlinson-Busza G, Syrigos
KN, Vile RG, Uster PS, Peters AM and Stewart JS: Pegylated
liposome-encapsulated doxorubicin and cisplatin enhance the effect
of radiotherapy in a tumor xenograft model. Clin Cancer Res.
6:4939–4949. 2000.PubMed/NCBI
|
|
14
|
Lluch A, Ojeda B, Colomer R, Barnadas A,
Massuti B, Casado A, Angeles C and Maroto P: Doxorubicin and
paclitaxel in advanced breast carcinoma: importance of prior
adjuvant anthracycline therapy. Cancer. 89:2169–2175. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yoshida M, Shimura T, Fukuda S, Mizoshita
T, Tanida S, Kataoka H, Kamiya T, Nakazawa T, Higashiyama S and Joh
T: Nuclear translocation of pro-amphiregulin induces
chemoresistance in gastric cancer. Cancer Sci. 103:708–715. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Brown JM and Attardi LD: The role of
apoptosis in cancer development and treatment response. Nat Rev
Cancer. 5:231–237. 2005.PubMed/NCBI
|
|
17
|
Cho SY, Jeong EM, Lee JH, Kim HJ, Lim J,
Kim CW, Shin DM, Jeon JH, Choi K and Kim IG: Doxorubicin induces
the persistent activation of intracellular transglutaminase 2 that
protects from cell death. Mol Cells. 33:235–241. 2012. View Article : Google Scholar
|
|
18
|
Chung LY, Tang SJ, Sun GH, Chou TY, Yeh
TS, Yu SL and Sun KH: Galectin-1 promotes lung cancer progression
and chemoresistance by upregulating p38 MAPK, ERK, and
cyclooxygenase-2. Clin Cancer Res. 18:4037–4347. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li W and Melton DW: Cisplatin regulates
the MAPK kinase pathway to induce increased expression of DNA
repair gene ERCC1 and increase melanoma chemoresistance. Oncogene.
31:2412–2422. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kubo T, Shimose S, Matsuo T, Sakai A and
Ochi M: Efficacy of a nitrogen-containing bisphosphonate,
minodronate, in conjunction with a p38 mitogen activated protein
kinase inhibitor or doxorubicin against malignant bone tumor cells.
Cancer Chemother Pharmacol. 62:111–116. 2008. View Article : Google Scholar
|
|
21
|
Souma Y, Nishida T, Serada S, Iwahori K,
Takahashi T, Fujimoto M, Ripley B, Nakajima K, Miyazaki Y, Mori M,
et al: Antiproliferative effect of SOCS-1 through the suppression
of STAT3 and p38 MAPK activation in gastric cancer cells. Int J
Cancer. 131:1287–1296. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li H, Wang X, Chen T and Qu J: p38
inhibitor SB203580 sensitizes the resveratrol-induced apoptosis in
human lung adenocarcinoma (A549) cells. J Biochem Mol Toxicol.
26:251–257. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zamzami N, Brenner C, Marzo I, Susin SA
and Kroemer G: Subcellular and submitochondrial mode of action of
Bcl-2-like oncoproteins. Oncogene. 16:2265–2282. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li X, Wu D, Shen J, Zhou M and Lu Y:
Rapamycin induces autophagy in the melanoma cell line M14 via
regulation of the expression levels of Bcl-2 and Bax. Oncol Lett.
5:167–172. 2013.PubMed/NCBI
|
|
25
|
Scheel-Toellner D, Raza K, Assi L, Pilling
D, Ross EJ, Lee WY, Curnow SJ, Buckley CD, Akbar AN, Lord JM and
Salmon M: Differential regulation of nuclear and mitochondrial
Bcl-2 in T cell apoptosis. Apoptosis. 13:109–117. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kernt M, Arend N, Buerger A, Mann T,
Haritoglou C, Ulbig MW, Kampik A and Hirneiss C: Idebenone prevents
human optic nerve head astrocytes from oxidative stress, apoptosis,
and senescence by stabilizing BAX/Bcl-2 ratio. J Glaucoma.
22:404–412. 2013. View Article : Google Scholar
|
|
27
|
Shi L, Chen J, Yang J, Pan T, Zhang S and
Wang Z: MiR-21 protected human glioblastoma U87MG cells from
chemotherapeutic drug temozolomide induced apoptosis by decreasing
Bax/Bcl-2 ratio and caspase-3 activity. Brain Res. 1352:255–264.
2010. View Article : Google Scholar : PubMed/NCBI
|
